| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2001 | WO2000054757A3 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 03/29/2001 | WO2000051576A3 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 03/29/2001 | WO2000049994A8 An aqueous non-alcoholic oral rinse containing benzocaine and carbomer |
| 03/29/2001 | WO2000047583A8 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 03/29/2001 | WO2000044386A8 Method for treatment of headache |
| 03/29/2001 | WO2000032255A9 Polymeric coatings with controlled delivery of active agents |
| 03/29/2001 | WO2000021515A9 Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
| 03/29/2001 | WO1999066922A8 Method of altering nutritional components of milk produced by a lactating animal |
| 03/29/2001 | WO1999063977A3 Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | DE19946289A1 Benzodiazepin-Derivate, deren Herstellung und Anwendung Benzodiazepine derivatives, their production and use |
| 03/29/2001 | DE19946184A1 Retinoid-containing emulsions with continuous water phase, for topical application e.g. for skin treatment, repair or renewal, having structured, polar, viscous oil phase to stabilize active agent |
| 03/29/2001 | DE19945982A1 Geschwindigkeitsbestimmte Partikel Certain particle velocity |
| 03/29/2001 | DE19945885A1 Use of gemifloxacin compounds, which can be active against bacterial strains resistant to other antibiotics, in treatment of infections caused by respiratory tract pathogenic bacteria |
| 03/29/2001 | DE19945810A1 Substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | DE19945302A1 Biphenylderivate als NHE-3-Inhibitoren Biphenyl as NHE-3 inhibitors |
| 03/29/2001 | DE19944767A1 N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel N-substituted 4-Aminopteridine, processes for their preparation and their use as medicaments |
| 03/29/2001 | CA2391976A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | CA2387529A1 Biphenyl derivatives as nhe-3 inhibitors |
| 03/29/2001 | CA2387520A1 Amine derivatives |
| 03/29/2001 | CA2386767A1 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385488A1 Systems and methods for opening obstructed biological conduits |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385479A1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof |
| 03/29/2001 | CA2385447A1 Pyrazole derivatives |
| 03/29/2001 | CA2385445A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 03/29/2001 | CA2385425A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2385105A1 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 03/29/2001 | CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2384829A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | CA2384827A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | CA2384296A1 Therapeutic quinazoline derivatives |
| 03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | CA2384284A1 Quinazoline derivatives |
| 03/29/2001 | CA2384282A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 03/29/2001 | CA2383510A1 Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction |
| 03/29/2001 | CA2383240A1 Polymer conjugates of ara-c and ara-c derivatives |
| 03/29/2001 | CA2383214A1 Treating allergic and inflammatory conditions |
| 03/29/2001 | CA2383211A1 Use of desloratadine for treating allergic and inflammatory conditions |
| 03/29/2001 | CA2383152A1 Agent for enhancing stamina and agent for promoting glycogen accumulation |
| 03/29/2001 | CA2383147A1 Mch antagonists |
| 03/29/2001 | CA2383131A1 Formulation |
| 03/29/2001 | CA2382547A1 Methods and compositions for treating platelet-related disosders |
| 03/29/2001 | CA2351673A1 Pharmaceutical antibacterial compositions |
| 03/29/2001 | CA2351482A1 Novel pharmacological activities of curcuma longa extracts |
| 03/29/2001 | CA2320556A1 N,n-dichlorinated omega amino acids and uses thereof |
| 03/28/2001 | EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/28/2001 | EP1086952A1 Therapeutic agents |
| 03/28/2001 | EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 03/28/2001 | EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 03/28/2001 | EP1086706A1 Stabilized compositions containing nootropic drugs |
| 03/28/2001 | EP1086701A2 Simethicone containing laxative composition |
| 03/28/2001 | EP1086700A2 A solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same |
| 03/28/2001 | EP1086699A1 Process for producing composite preparation containing nucleic acid |
| 03/28/2001 | EP1086698A1 Agents for relieving side effects of adrenal cortex hormone |
| 03/28/2001 | EP1086697A2 New combination of formoterol and budesonide |
| 03/28/2001 | EP1086696A2 Immunopotentiating and infection protective agent and production thereof |
| 03/28/2001 | EP1086695A1 Antiviral compositions comprising yohimbine as active principle |
| 03/28/2001 | EP1086694A2 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
| 03/28/2001 | EP1086693A1 Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof |
| 03/28/2001 | EP1086692A2 Estrogen agonists and antagonists for multiple indications |
| 03/28/2001 | EP1086690A2 Pharmaceutical formulations of cefaclor |
| 03/28/2001 | EP1086689A2 Pharmaceutical formulations of cefaclor |
| 03/28/2001 | EP1086688A1 Suspension aerosol formulations |
| 03/28/2001 | EP1086682A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation |
| 03/28/2001 | EP1086239A1 Formulations for electroporation |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086118A1 Vitamin b 12? derivatives and methods for their preparation |
| 03/28/2001 | EP1086113A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 03/28/2001 | EP1086112A2 1-galactose derivatives |
| 03/28/2001 | EP1086109A1 Process for preparing crystalline salts of amoxycillin |
| 03/28/2001 | EP1086108A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors |
| 03/28/2001 | EP1086107A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086105A1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/28/2001 | EP1086104A1 Fused phenoxymethyl carbapenem antibacterials |
| 03/28/2001 | EP1086103A1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1? specific ligands |
| 03/28/2001 | EP1086102A1 Acetylcholine enhancers |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086100A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/28/2001 | EP1086097A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086095A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086094A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1086092A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
| 03/28/2001 | EP1086091A1 Hiv integrase inhibitors |
| 03/28/2001 | EP1086088A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 03/28/2001 | EP1086087A1 Crystalline efavirenz |